← Open Payments lookup

ALEXANDER CASHMAN: Open Payments

NPI 1912401712 · BATON ROUGE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$396 in 20 payments from 9 companies in 2025. Trend: 2023 $1,198 · 2024 $429 · 2025 $396

Food & beverage: $396
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.4$107
ABBVIE INC.5$95
E.R. Squibb & Sons, L.L.C.4$64
Teva Pharmaceuticals USA, Inc.2$37
Alkermes, Inc.1$24
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$19
Lundbeck LLC1$18
Luye Pharma (USA) Ltd.1$17
Takeda Pharmaceuticals U.S.A., Inc.1$16

Products named: INGREZZA, VRAYLAR, COBENFY, ARISTADA, UZEDY, CAPLYTA, REXULTI, ERZOFRI EXTENDED-RELEASE.

Industry payments across LA — which companies pay providers there.